SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Malta Medicines Authority concludes GMP inspection at Alkem Laboratories’ manufacturing facility

10 Dec 2025 Evaluate

Malta Medicines Authority has concluded GMP inspection at Alkem Laboratories’ manufacturing facility located at Daman, India. The said inspection was conducted from December 05, 2025 and concluded on December 09, 2025, with no critical observations, three major observations and a few minor observations. The Company shall however address the said observations within the stipulated timeframe for closure of the same.

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.

Alkem Laboratories Share Price

5576.80 -14.05 (-0.25%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×